MICROPORT NEURO (02172) spent 986,500 Hong Kong dollars to repurchase 100,000 shares on May 13th.
Minimally Invasive Neurosciences (02172) announced that on May 13, 2026, the company will spend 986,500 Hong Kong dollars to repurchase 100,000 shares, at a repurchase price of 9.85-9.9 Hong Kong dollars per share.
MICROPORT NEURO (02172) announced on May 13, 2026, that the company is going to buy back 100,000 shares at a cost of 986,500 Hong Kong dollars, with a buyback price per share ranging from 9.85 to 9.9 Hong Kong dollars.
Related Articles
SAMSONITE (01910) released its first quarter results, with a net profit attributable to equity holders of $32.2 million, a decrease of 33.2% year-on-year.
LIANLIAN(02598): Suggesting appointment of Deloitte as the new auditor.
PW MEDTECH (01358) announced on May 13th that it spent 359,900 Hong Kong dollars to repurchase 305,000 shares.
SAMSONITE (01910) released its first quarter results, with a net profit attributable to equity holders of $32.2 million, a decrease of 33.2% year-on-year.
LIANLIAN(02598): Suggesting appointment of Deloitte as the new auditor.
PW MEDTECH (01358) announced on May 13th that it spent 359,900 Hong Kong dollars to repurchase 305,000 shares.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
